Answers are grounded in this paper and cite their sources.
These results may indicate the clinical and pharmacological relevance UGT2B10 in pediatric HSCT setting. With this systematic computational methodology, we provide a rational-, time-, and cost-effective way to identify and prioritize the interesting putative substrates or inhibitors of UGT2B10 for further testing in in vitro experiments.
No takes yet. Share an insight, caveat, or question.
Robin et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: